Literature DB >> 6257787

Age-associated changes in Epstein-Barr virus-induced human lymphocyte autoantibody responses.

S Fong, C D Tsoukas, L A Frincke, S K Lawrance, T L Holbrook, J H Vaughan, D A Carson.   

Abstract

In the present investigation we have studied the capacity of the Epstein-Barr virus (EBV), a ubiquitous human B lymphocyte polyclonal activator, to induce cultured peripheral blood lymphocytes from umbilical cords, young adults (20 to 40 yr old), and elderly adults (75 to 90 yr old) to form IgM antibodies to human IgG or human thyroglobulin. The EBV preparation used was shown to exert its B cell stimulatory effect independently of T cell-suppressor effects. The cultures were studied in limiting dilution analyses, and the data were taken to represent relative numbers of B cell precursors of autoantibody-forming cells in the 3 age groups. The results showed: 1) the EBV-inducible IgM anti-IgG and anti-thyroglobulin-producing cells increased in number from birth to old age; 2) the rise occurred at different times of life for the 2 autoantibodies, anti-IgG reactive B cells increasing between birth and young adulthood, and anti-thyroglobulin reactive B cells between young adulthood and old age; 3) the apparent relative avidity of the anti-IgG for antigen was higher in the elderly adults than in the younger adults. We believe these findings are determined by differences in the frequencies of the respective self-reactive B cells in the circulation. What physiologic or environmental factors determine the differential expansions of the human autoreactive B lymphocytes for IgG and thyroglobulin are not known. It seems possible that individual variations in the sizes of these pools may be a factor in determining susceptibility to autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257787

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Antigenicity, storage, and aging: physiologic autoantibodies to cell membrane and serum proteins and the senescent cell antigen.

Authors:  M M Kay; K Sorensen; P Wong; P Bolton
Journal:  Mol Cell Biochem       Date:  1982-11-26       Impact factor: 3.396

2.  Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid.

Authors:  M J Welch; S Fong; J Vaughan; D Carson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 3.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

4.  Physiology and pathology of rheumatoid factors.

Authors:  D A Carson; J L Pasquali; C D Tsoukas; S Fong; S F Slovin; S K Lawrance; L Slaughter; J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1981

5.  Antigenic mimicry of mammalian intermediate filaments by mycoplasmas.

Authors:  K S Wise; R K Watson
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  In vitro autoantibody production by normal adult and cord blood B cells.

Authors:  D S Pisetsky; D F Jelinek; L M McAnally; C F Reich; P E Lipsky
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  Cord blood contains cells secreting antibodies to nervous system components.

Authors:  S Fredrikson; J Sun; B G Xiao; H Link
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Staphylococcus aureus Cowan I. Potent stimulus of immunoglobulin M rheumatoid factor production.

Authors:  A I Levinson; L Tar; C Carafa; M Haidar
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments.

Authors:  R S Fujinami; M B Oldstone; Z Wroblewska; M E Frankel; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.